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Abstract Purinergic P2 receptors are a class of plasma
membrane receptors that are express in many tissues and are
ligated by extracellular nucleotides [such as adenosine
triphosphate (ATP), adenosine diphosphate (ADP), uridine
5′-triphosphate (UTP) and uridine 5′-diphosphate (UDP)],
which are released as a consequence of cell damage, cell
stress, bacterial infection or other noxious stimuli. According
to the molecular structure, P2 receptors are divided into two
subfamilies: P2X and P2Y receptors. The P2X receptors are
ligand-gated channels, whereas P2Y receptors are G-protein-
coupled seven-membrane-spanning receptors. Several studies
indicate that nucleotides play an important role in immune
response modulation through their action on multiple cell
types, including monocytes, mast cells, dendritic cells,
neutrophils, and eosinophils. Recent work by our group and
others identified extracellular nucleotides as chemotaxins for
various human immune cells, including eosinophils, neutro-
phils and dendritic cells. In this review, we summarise recent
findings in this field and put forward a hypothesis on the role
of P2 receptors in the early recruitment of human immune
cells to the site of inflammation.
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Introduction
Cell migration plays a key role in a wide variety of
biological processes, such as embryogenesis, development,
angiogenesis, haematopoiesis, immune response and in-
flammation. In inflammation and host defence, the targeted
trafficking of immune cells to tissues and/or lymphoid
organs is one of the essential steps. Migration of the
different leukocytes is tightly controlled by chemokines.
These chemotactic cytokines are secreted proteins with a
molecular weight of 8–10 kDa, which direct cellular traffic
along ingeniously regulated concentration gradient in the
extracellular space. Based on amino acid alignments,
chemokines are divided into four families. According to
the position and the spacing of the first two conserved
cysteines or the lack of them, these families are distin-
guished as either C, CC, CXC or CX3C. Until now, C and
CX3C are composed of only one member each, lympho-
tactin and fractalkine, respectively, whereas CC and CXC
each consist of numerous, well-characterised members [1,
2]. The chemotactic effects of these molecules are mediated
due to their interactions with different specific serpentine
receptors that span the plasma membrane seven times and
belong to the G-protein-coupled receptor family.
Besides chemokines, many constitutive molecules can
regulate the function of leukocytes and thereby modulate
immune responses, e.g. following tissue damage, intracel-
lular localised substances can be released into the extracel-
lular space. For this reason, an increase of the extracellular
concentration of certain molecules can be a very simple
sign of cell damage. However, for constitutive molecules to
function as chemotaxins, it is essential that they are
recognised by immune system migration cells. In the past
few years, evidence has accumulated strongly suggesting
that nucleotides fulfil these requirements. They are present
at high concentrations (5–10 mM) in the cytoplasm of all
cells, whereas in the extracellular compartment, their
concentration is in the nanomolar range. Nucleotides can
be released into the extracellular space via nonlytic
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e-mail: marco.idzko@uniklinik-freiburg.demechanisms through regulated transport; e.g. adenosine tri-
phosphate (ATP) has been reported to be secreted by different
cell types in a broad variety of conditions, such as shear stress,
endotoxin stimulation, or at sites of platelet aggregation [3, 4]
Hence, in tissues, nucleotides are able to generate concentra-
tion-dependent gradients, which can serve as chemotactic
signals for different immune cells, causing migration.
P2 receptors
P2 receptors are subdivided on the basis of pharmacolog-
ical, functional and cloning data into two families: the
P2YR and P2XR [5–8]. P2YR are seven-membrane-
spanning, G-protein-coupled receptors, and eight different
P2YR subtypes have been cloned so far (P2Y1, P2Y2,
P2Y4,P 2 Y 6, P2Y11, P2Y12, P2Y13 and P2Y14)[ 5, 9, 10].
Activation of P2YR induces phospholipase C activation,
inositol triphosphate generation, Ca
2+ release from intracel-
lular stores, and/or stimulation/inhibition of adenylate
cyclase. Extensive pharmacological studies performed in
P2Y transfected cells revealed that P2Y1, P2Y11,P 2 Y 12 and
P2Y13 selectively interact with ATP and/or adenosine
diphosphate (ADP), whereas uridine 5′-triphosphate (UTP)
and uridine 5′-diphosphate (UDP) are inactive [11–15]. In
contrast the P2Y2, P2Y4 and P2Y6 subtypes are responsive
to uridine nucleotides [16–18]. Whereas ATP and UTP
activate P2Y2 with similar efficiency, UTP and UDP are
most the potent agonists at P2Y4 and P2Y6, respectively
[16–18]. In addition, it has been shown that P2Y14
specifically responds to UDP glucose and related sugar
nucleotides but not to ATP, ADP, UTP or UDP [5, 9, 19,
20]. P2YR have been shown to modulate multiple cell
function of various human immune cells, including cyto-
kine release from dendritic cells, reactive oxygen metabo-
lite production from neutrophils and eosinophils or
chemokine release from airway epithelial cells [20–23].
P2XR are multimeric ligand-gated plasma-membrane
ion channels activated by extracellular ATP and selective
for monovalent and divalent cations [8, 24, 25]. At this
time, seven different monomers have been cloned: the
P2X1–P2X7 subtypes. Activation of P2XR leads to
increased plasma membrane permeability to ions (Na
+,
K
+, and Ca
2+) and induction of apoptosis in human immune
cells [22, 26] . In contrast to P2YR, the only currently
known physiological ligand for all P2XR subtypes is ATP.
P2 receptors and migration of neutrophils
The first report that extracellular nucleotides can modulate
human neutrophil function was a paper by Ward et al.
showing that ATP and ADP can induce superoxide anion
formation [27, 28]. Furthermore, it has been shown that
human neutrophils or human promyelocytic HL60 cells
respond to ATP, ATPγS and UTP with an increase in
intracellular Ca
2+ concentration via a pertussis toxin-
sensitive G-protein receptor that coupled to the inositol
phospholipid signaling system, suggesting involvement of
P2Y subtypes [27, 29–33]. Activation of these intracellular
signal-transduction systems is of great interest in the light
of neutrophil recruitment to the site of inflammation, as
increase in Ca
2+ concentration is an important step in
human neutrophil migration [34–36]. Furthermore, it has
been shown that ATP also increases membrane expression
of CD11b/CD18 and adhesion to albumin-coated polysty-
rene latex beads [37].Up-regulation of these molecules
enhances the adhesion of neutrophils to other cells, e.g.
between neutrophils and pulmonary endothelial cells, and
could be of relevance for neutrophil migration across the
vessel wall. However, after earlier observations suggesting
that nucleotides might be chemoattractant for human
neutrophils, it was not until the end of the 1990s that ATP
and UTP were shown, by Verghese et al. [103] to induce
actin polymerisation and chemotaxis in human neutrophils
via the activation of P2Y2 (formerly known as P2U) receptor.
Surprisingly, the first reverse transcripaise polymerase
chain reaction (RT-PCR) data revealed that human neutro-
phils express only P2Y4 and P2Y6 but not P2Y1 and P2Y2
receptors [38]. However, recent reports showed that human
neutrophils also express messenger ribonucleic acid
(mRNA) for the P2Y2 and P2Y11 receptor subtypes [39,
40]. Among the P2X receptors, so far, only the present of
the P2X7 receptor has been shown by Northern blotting and
immunocytochemistry [41]. Because increased extracellular
nucleotide concentrations are associated with cell damage/
injury and human neutrophils are the initial cell type found
at tissue injury sites, the conclusion could be drawn that
extracellular nucleotides among other mediators are in-
volved in the recruitment of neutrophils to the site of
inflammation.
P2 receptors and recruitment of human eosinophils
Besides neutrophils, eosinophils also express P2 receptors.
Several studies showed that human eosinophils express
mRNA for the following P2Y and P2X subtypes: P2Y1,
P2Y2,P 2 Y 4, P2Y6, P2Y11,P 2 Y 14, P2X1, P2X4 and P2X7
[23, 42–44]. Stimulation of P2 receptors expressed by
eosinophils induces multiple cell responses, including
production of reactive oxygen metabolites and secretion
of eosinophil cationic protein (ECP) [23, 26].
Burgers and colleagues [45] showed that ATP, secreted
by thrombin-activated platelets, was able to raise eosinophil
intracellular Ca
2+ concentration and made the cells chemo-
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confirmed by the identification of eosinophil P2Y and P2X
receptors [42, 44] and the observations that nucleotides also
induce up-regulation of adhesion molecule CD11b and
actin polymerisation to important features involved in blood
eosinophil recruitment to tissue [23, 42, 44].
In addition to direct chemotactic influences, ATP might
also have indirect effects on eosinophil recruitment. We
recently showed that ATP and UDP induce secretion of
interleukin (IL)-8 by eosinophils [26]. This chemokine is a
potent attractor for eosinophils themselves (and neutro-
phils), i.e. they are able to recruit more cells to inflamma-
tion sties. Increased secretion of IL-8 has been described in
eosinophils from patients with bronchial asthma or atopic
dermatitis [46]. Moreover, IL-8 concentration in bronchoal-
veolar fluids from asthmatic patients is increased signifi-
cantly in comparison with that of healthy subjects [46];
therefore, one can suggest the involvement of different
nucleotides in the direct or IL-8-mediated recruitment of
eosinophils and thus in the development and maintenance
of allergic diseases.
P2 receptors and mast cells
Mast cells are situated around blood vessels and nerves,
especially at interfaces with the external environment,
emphasising their role in immunity. They express several
mRNAs that encode P2XR and P2YR subtypes [47, 48].
Human mast cells express P2X1 and P2X4, whereas the
P2X7 receptor subtype is only expressed by human-cord-
blood-derived mast cells when activated with anti-immuno-
globulin (Ig)E [47]. Among the P2Y receptors, the presence
of P2Y1,P 2 Y 2,P 2 Y 11, P2Y12 and P2Y13 subtypes were
shown by RT-PCR [48]. Moreover, ATP and UTP enhance
histamine release by human lung mast cells stimulated by
cross-linkage of the fragment crystallisable (Fc)ɛRI [49].
This effect is attributed to the P2Y2 receptor. Data on
chemotactic effects of nucleotides on mast cells are rare, but
there is evidence that they might effect the migration of these
cells. For example, McCloskey and colleagues showed that
the nucleotides ADP, ATP and UTP are effective chemo-
attractants for rat-bone-marrow-cultured mast cells [50].
However, whether nucleotides can also induce migration of
human mast cells remains to be elucidated
P2 receptors and lymphocytes
The first evidence for a role of extracellular nucleotides in
human lymphocyte responses has been present for some
time [51–53], but a systemic analysis of the expression and
function of P2 receptors in human lymphocytes was only
started at the end of the 1980s [30, 54–57]. Human B
lymphocytes express both P2X and P2Y receptors [58, 59].
The presence of different P2Y receptors is indicated by the
ability of ATP and many other nucleotides to trigger Ca
2+
release from intracellular stores [60, 61] and the finding of
P2Y1,P 2 Y 2,P 2 Y 4 and P2Y6 receptor-specific mRNA in
lymphocytes [38]. Different studies suggest that human B
cells express at least P2X7 receptor [22], but the identification
of other P2X receptor subtypes is limited by the absence of
specific antibodies [62, 63]. Nevertheless, confocal microsco-
py studies using anti-P2X polyclonal antibodies suggest the
presence of P2X1,P 2 X 2,P 2 X 4 and P2X7 subtypes on human
Bl y m p h o c y t e s[ 59]. However, despite the presence of
functional P2 receptors, data about chemotactic effects on B
lymphocytes induced by nucleotides are still missing.
Functional and pharmacologic studies revealed that
human peripheral T lymphocytes express P2X-like ATP-
activated channels, most likely P2X1, P2X4 and P2X7,[ 22,
64, 65]. Functional activity of the P2X receptors on T cells
has been shown by a large influx of Na
+ and Ca
++ from the
extracellular medium caused by ATP and 3′-O-(4-benzoyl)
benzoyl-ATP (Bz-ATP) [65].
The expression of P2Y receptors subtypes is still unclear,
and whereas Baricordi and coworkers described a lack of
functional P2Y receptors expression [65], recent studies
using complete lymphocyte populations (T and B cells)
could detected all the target genes for P2Y1, P2Y2, P2Y4,
P2Y6, P2Y11, P2Y12 and P2Y13 [66]. However, a functional
expression of different P2Y receptors on human T
lymphocytes has not been proven.
Studies showing that activation of the P2X7 receptor by
ATP and Bz-ATP induced shedding of CD23 and L-selectin
from B and T lymphocytes of a B-chronic lymphocytic
leukaemia (B-CLL) patient and from normal subjects, a
classic effect of chemoattractants [67–70], leads to the
assumption that the P2X7 receptor might be involved in the
transendothelial migration of lymphocytes [71, 72]. But
elegant experiments from Chen and coworkers using P2X7
antagonist in in vitro migration assays indicated that ATP is
neither a chemoattractant that stimulates transmigration of
lymphocytes nor an agonist that mediates the global L-
selectin loss during transendothelial migration [73]. In any
case a direct effect of extracellular nucleotides on T and B
lymphocyte migration has not yet been investigated and,
therefore, the role of nucleotides in the recruitment of
lymphocytes remains unclear.
P2 receptor in monocyte/macrophages
Although the first report on a potential role of exogenous
nucleotides on mouse macrophage function was a paper by
Cohn and Parks from 1967 [74], a systemic investigation
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1990s [30, 38, 75–78]. Freshly isolated blood monocytes
have been shown to express mRNA for the following P2Y
and P2X subtypes: P2Y1,P 2 Y 2,P 2 Y 4,P 2 Y 6,P 2 Y 11,
P2Y12,P 2 Y 13 P2X1,P 2 X 4 and P2X7 [38, 66, 79].
However, other investigations found a lack of functional
P2X7 in these cells, whereas the receptor appears during
maturation of monocytes to macrophages [22]. Besides
P2X7 receptors, human macrophages or macrophage cell
lines have been described to express P2Y2,P 2 Y 4 and P2Y6
receptors [30, 80, 81].
Activation of P2 receptors expressed by human mono-
cytes/macrophages induces multiple cell responses, includ-
ing increase of intracellular calcium concentration,
induction of apoptosis, generation of reactive oxygen
intermediates, NO generat i o na n ds e c r e t i o no fI L - 1 β,
tumour necrosis factor (TNF)-α or IL-18 [22, 30, 77, 79,
82, 83]. In the light of migration, it is of great interest that
extracellular ADP causes increased surface expression of
MAC-1 (alpha M beta 2 integrin, CD11b/CD18) on
monocytes [84] and that nucleotides can induce the
adherence of monocytes to surfaces [38], which could be
of relevance for monocyte migration across the vessel wall.
Accordingly, migration of the mouse macrophage line J774
towards ADP has been demonstrated [50]. Interestingly,
Warny et al. demonstrated that UDP activates IL-8 gene
expression and IL-8 release in human monocytic cells [85].
Because IL-8 is a central mediator in inflammation and an
important chemotactic factor for various cells, including
neutrophils, eosinophils and CD16+ natural killer (NK)
cells [46, 86–89], UDP [through its action on dendritic cells
(DC)] might be indirectly involved in the recruitment of
these cells to the side of inflammation. However, at this
t i m e ,n oi n f o r m a t i o no nt he chemotactic activity of
nucleotides on human monocytes/macrophages is available.
P2 receptors in dendritic cells
DCs are powerful antigen-presenting cells that circulate in
the bloodstream or reside in peripheral tissues. They are
characterised by a high antigen uptake capacity, recognition
of constitutive or inducible endogenous “danger signals”
provided by surrounding cells and a high responsiveness to
chemotactic signals. The migratory ability of DCs is one of
the main features in the initiation of immune responses.
After acquiring antigens in the peripheral tissue, DCs
migrate to the draining mediastinal lymph nodes to activate
naive T cells [90–92]. Besides this “classic” action, some
evidence also suggests that tissue-resident DCs are able to
uptake tissue antigens and to migrate to the afferent lymph
nodes, even in the absence of inflammatory conditions, thus
contributing to tolerance maintenance [93, 94].
In the last few years, DCs came into the focus of
researchers of the purinergic field, and the role of P2
receptors in DC migration came to the fore. RT-PCR
analysis revealed that human DCs express a broad variety
mRNAs for at least four subtypes of the P2X receptor
family (P2X1, P2X4, P2X5, P2X7) and eight subtypes of the
P2Y receptor family (P2Y1,P 2 Y 2, P2Y4, P2Y6,P 2 Y 11
P2Y12 P2Y13,P 2 Y 14)[ 95–99].
First, studies by Liu et al. revealed that at least activation
of the P2Y1,P 2 Y 2 and P2Y4 mediates calcium release from
intracellular storage. Furthermore, the observation that DCs
redirect their dendrites towards a nearby patch pipette
leaking ATP suggested that P2YR might mediate DC
chemotactic response [96]. Indeed, ATP and UTP, probably
via activation of the P2Y2, as well as ADP (via P2Y1?)
turned out to be potent chemotactic stimuli for immature
but not for mature DCs [100] In contrast, P2X receptor
activation had only marginal chemotactic activity in both
immature and mature DCs. Chemotaxis was paralleled by
other intracellular signalling events, such as actin polymer-
isation and intracellular Ca
2+ mobilisation. Recently, UDP
could be added to the list of chemoattractant nucleotides, as
it has been shown that UDP via binding to the P2Y6
receptor increased intracellular calcium, induced actin
polymerisation and migration of immature, but again not
mature, DCs [101]. The discrepancy between the respon-
siveness to extracellular nucleotides of immature and
mature DCs could be explained by functional studies. They
revealed a selective down-regulation of the Gi/o protein-
coupled chemotactic P2Y receptor responsiveness during
maturation. Surprisingly, immature and mature DCs
expressed similar amounts of mRNA for the purinergic
receptor subtypes P2Y1, P2Y2,P 2 Y 4, P2Y6, P2Y11, P2X1,
P2X4 and P2X7 [100]. DC maturation encompasses a
coordinated down-regulation of inflammatory chemokine
receptors (CCR1, CCR2, CCR5 and CXCR1) and induction
of CCR7 and CXCR4 [2]. In addition, during maturation,
functional down-regulation of chemotaxis-regulating P2Y
receptors are uncoupled to chemotaxis-associated signal
transduction pathways. As a result, DCs lose sensitivity to
inflammatory chemokines as well as to the nucleotides
ATP, ADP, UTP and UDP.
In addition, nucleotides can modulate the migration of
DCs to chemokines, as immature and matured DCs
stimulated with ATP gain the ability to migrate in response
to CXC ligand (L)12 and CCL12 [102]. However, in
contrast, Schnurr et al. reported that ATP through P2Y11
signalling could inhibit CCL21, induce migration of
immature and mature monocyte-derived DCs and CD1a
+
dermal DCs but not of CD1c
+ peripheral blood DCs or IL-
3R
+ plasmacytoid DCs [98]. This controversy could be due
to differences in the blood donors or preparation of
monocyte-derived DCs in the different laboratories.
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nucleotides are also involved indirectly via their action on
DCs in the trafficking of other leukocytes through the
release of chemokines. For example, ATP up-regulates the
constitutive production of CCL22 [macrophage-derived
chemokine (MDC)] and inhibits the lipopolysaccharide
(LPS)-induced secretion of CXCL10 (IP-10) and CCL5
(RANTES), resulting in selectively impaired recruitment of
type 1 but not type 2 T cells, suggesting a nucleotide-
mediated communication between DCs and T cells—an
important event during antigen presentation in vivo [102].
In accordance, UDP can enhance the LPS-mediated release
of chemotactic factor IL-8 via P2Y6 from mature DCs
[101], so again, UDP might be indirectly involved in the
recruitment of neutrophils, eosinophils and CD16+ NK
cells to the side of inflammation.
In sum, activation of DCs by extracellular nucleotides
leads to multiple cell responses, which results in a direct
migration of DCs and also maybe indirect (DC-mediated)
recruitment of other immune cells to the site of inflamma-
tion.
Conclusion
Over the last few years, several studies have implied that
extracellular nucleotides—which are actively released or
diffuse out of mechanically stressed, infected or injured
cells—might be involved in the early recruitment of
immune cells to the site of inflammation/cell damage. In
these in vitro experiments, it has been shown that
extracellular nucleotides (mainly by activating P2YR
subtypes) are direct chemoattractants for human neutro-
phils, eosinophils and DCs and/or they can modulate the
chemokine production of eosinophils, monocytes and DCs,
which might then influence the migration capacity of other
immune cells. However, whether nucleotides play a role in
the migration of immune cells in vivo still remains to be
elucidated.
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